2025-12-28 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce (CRM) based on the provided data.

**1) Return Rate Comparison**

*   **Company Overview:** Salesforce Inc. is a cloud-based software company that provides customer relationship management (CRM) service.
*   **CRM Cumulative Return:** -1.84%
*   **VOO (S&P 500) Cumulative Return:** 103.21%
*   **Divergence:** -105.0 (Relative Divergence: 7.0)

**Analysis:** CRM has significantly underperformed the S&P 500 (VOO) over the period examined.  The divergence is substantial (-105.0). The relative divergence of 7.0 suggests that this divergence is near the lower end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha    | Beta    | Cap(B) |
|------------|---------|--------|----------|---------|--------|
| 2015-2017  | 39.0%   | 70.6%  | 10.0%    | -0.0    | 97.3   |
| 2016-2018  | 34.0%   | 73.5%  | 19.0%    | 0.1     | 130.4  |
| 2017-2019  | 22.0%   | 73.5%  | 0.0%     | 0.4     | 154.8  |
| 2018-2020  | 14.0%   | 73.5%  | -10.0%   | 0.4     | 211.8  |
| 2019-2021  | 37.0%   | 71.9%  | -10.0%   | 0.7     | 241.9  |
| 2020-2022  | -78.0%  | 74.7%  | -78.0%   | 0.4     | 126.2  |
| 2021-2023  | -47.0%  | 76.6%  | -49.0%   | -0.6    | 250.5  |
| 2022-2024  | -42.0%  | 76.6%  | -63.0%   | -0.4    | 318.3  |
| 2023-2025  | 10.0%   | 76.6%  | -58.0%   | -2.1    | 253.3  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows a wide range of performance, with strong growth in earlier periods followed by significant declines in more recent periods.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant potential for losses.
*   **Alpha:** Alpha is largely negative in recent years, suggesting that CRM has underperformed relative to its risk-adjusted benchmark.
*   **Beta:** Beta fluctuates, indicating varying degrees of correlation with the market. A negative beta in the most recent periods suggests an inverse correlation.
*   **Cap(B):** Market capitalization generally increased over the observed period.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 266.08
*   **Previous Close:** 265.26
*   **Change:** 0.31
*   **5-day SMA:** 263.86
*   **20-day SMA:** 255.75
*   **60-day SMA:** 248.01

**Analysis:** The stock is trading above its 5-day, 20-day, and 60-day Simple Moving Averages (SMAs), indicating a short-term upward trend.  The slight increase from the previous close suggests a mild positive momentum.

**3) Indicators**

*   **MRI:** 1.0 (High Investment Recommended)
*   **RSI:** 59.24
*   **PPO:** 0.30
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** -0.6 (short-term decline)
*   **Expected Return (%):** -639.9

**Analysis:**

*   The Market Risk Indicator (MRI) suggests a high investment recommendation; however, this should be viewed cautiously in light of other indicators.
*   The RSI of 59.24 is approaching the overbought territory (typically above 70).
*   The PPO (Percentage Price Oscillator) is slightly positive, which aligns with short-term rising trend indicated by SMAs.
*   The hybrid signal suggests a buy recommendation, but the MRI used in that signal is lower (0.8).
*   The negative change in relative divergence indicates short-term underperformance.
*   The very large negative expected return (-639.9%) is concerning, suggesting that, based on the model, the stock is significantly overvalued or faces substantial headwinds.

**4) Recent News & Significant Events**

*   **Agentforce AI Momentum:** Positive news about Salesforce's AI initiatives.
*   **AI Winner:**  Suggests confidence in Salesforce's future in AI.
*   **Buy Signal for 2026:** Indicates potential for future growth.
*   **"Holy Grail":**  Hyperbolic, but suggests positive developments.
*   **Buy Salesforce Stock Cheaply?:**  Indicates potential undervaluation.
*   **High Margins, Discount:** Suggests a buying opportunity.

**Analysis:** Recent news sentiment appears generally positive, focusing on AI initiatives, potential undervaluation, and future growth prospects.  This contrasts with the negative signals from the return comparison and expected return indicator.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean:** 1.64 (~Buy)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.06 / 475.00 / 223.00
*   **Recent Rating Changes:** None available (indicated by empty parentheses).

**Analysis:** Analyst consensus is positive, with a "Buy" rating and a significant average target price above the current price.  The lack of recent rating changes suggests stability in analyst outlook (or a lack of updates).

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-12-04 | 2.20 | 10.26 B$   |
| 2025-09-04 | 1.97 | 10.24 B$   |
| 2025-05-29 | 1.61 | 9.83 B$    |
| 2024-12-04 | 1.60 | 9.44 B$    |
| 2025-12-04 | 1.60 | 9.44 B$    |

**Analysis:** The data show consistent revenue growth over the past few quarters, with EPS also showing an increasing trend. The increase from 1.6 to 2.2 is encouraging.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-10-31   | $10.26B   | 78.02%        |
| 2025-07-31   | $10.24B   | 78.10%        |
| 2025-04-30   | $9.83B    | 76.96%        |
| 2025-01-31   | $9.99B    | 77.81%        |
| 2024-10-31   | $9.44B    | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-10-31   | $60.02B   | 3.48%     |
| 2025-07-31   | $61.33B   | 3.08%     |
| 2025-04-30   | $60.67B   | 2.54%     |
| 2025-01-31   | $61.17B   | 2.79%     |
| 2024-10-31   | $58.52B   | 2.61%     |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been consistently increasing, and the profit margin is exceptionally high and stable, indicating strong operational efficiency.
*   **Capital and Profitability:** Equity is relatively stable, and Return on Equity (ROE) has increased in the most recent quarter, suggesting improved profitability relative to shareholders' equity.

**7) Comprehensive Analysis**

CRM presents a mixed picture.

**Positive Signals:**

*   **Recent Positive News:** Focus on AI initiatives and potential undervaluation.
*   **Analyst Buy Consensus:** Strong analyst support with a high target price.
*   **Recent Earnings Growth:** Increasing revenue and EPS.
*   **High Profit Margins:** Demonstrates strong operational efficiency.
*   **Rising ROE:** Indicates improving profitability for shareholders.
*   **Recent SMA Indicators:** suggests a mild positive momentum.

**Negative Signals:**

*   **Significant Underperformance:** CRM has drastically underperformed the S&P 500.
*   **Negative Alpha:** Suggests underperformance relative to risk-adjusted benchmarks.
*   **High Maximum Drawdown:** Potential for significant losses.
*   **Low Relative Divergence:** The divergence is near the lower end of its historical range.
*   **Extremely Negative Expected Return:**  Indicates a potential overvaluation or significant headwinds.

**Conclusion:**

The investment decision regarding CRM requires careful consideration. While recent news, analyst ratings, and financial performance show positive trends, the historical underperformance, negative alpha, and extremely negative expected return are serious concerns.

The Market Risk Indicator (MRI) suggests a "High Investment Recommended," but this should be tempered by the negative signals. A prudent approach would involve further investigation into the reasons for the negative expected return and careful risk management. The positive news surrounding AI initiatives could be a potential catalyst for future growth, but this needs to be weighed against the existing challenges.

**In summary, while there are positive aspects to consider, the negative signals, especially the underperformance compared to the S&P 500 and the extremely negative expected return, warrant caution. A deeper analysis is needed before making an investment decision.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.